
1. Viruses. 2016 Jun 15;8(6). pii: E98. doi: 10.3390/v8060098.

Identification of Vimentin as a Potential Therapeutic Target against HIV
Infection.

Fernández-Ortega C(1), Ramírez A(2), Casillas D(3), Paneque T(4), Ubieta R(5),
Dubed M(6), Navea L(7), Castellanos-Serra L(8), Duarte C(9), Falcon V(10), Reyes 
O(11), Garay H(12), Silva E(13), Noa E(14), Ramos Y(15), Besada V(16), Betancourt
L(17).

Author information: 
(1)Center for Genetic Engineering and Biotechnology, Ave 31/158 and 190,
Cubanac&#225;n, Playa, P.O. Box 6162, Havana 10600, Cuba.
celia.fernandez@cigb.edu.cu.
(2)Center for Genetic Engineering and Biotechnology, Ave 31/158 and 190,
Cubanac&#225;n, Playa, P.O. Box 6162, Havana 10600, Cuba.
anna.ramirez@cigb.edu.cu.
(3)Center for Genetic Engineering and Biotechnology, Ave 31/158 and 190,
Cubanac&#225;n, Playa, P.O. Box 6162, Havana 10600, Cuba.
dionne.casillas@cigb.edu.cu.
(4)Center for Genetic Engineering and Biotechnology, Ave 31/158 and 190,
Cubanac&#225;n, Playa, P.O. Box 6162, Havana 10600, Cuba.
taimi.paneque@cigb.edu.cu.
(5)Center for Genetic Engineering and Biotechnology, Ave 31/158 and 190,
Cubanac&#225;n, Playa, P.O. Box 6162, Havana 10600, Cuba.
raimundo.ubieta@cigb.edu.cu.
(6)Laboratory for AIDS Research, Carretera de Tapaste y Autopista Nacional, San
Jos&#233; de las Lajas, Mayabeque CP 32700, Cuba. cicdc@infomed.sld.cu.
(7)Laboratory for AIDS Research, Carretera de Tapaste y Autopista Nacional, San
Jos&#233; de las Lajas, Mayabeque CP 32700, Cuba. riverora@infomed.sld.cu.
(8)Center for Genetic Engineering and Biotechnology, Ave 31/158 and 190,
Cubanac&#225;n, Playa, P.O. Box 6162, Havana 10600, Cuba.
lilacastellanos@infomed.sld.cu.
(9)Center for Genetic Engineering and Biotechnology, Ave 31/158 and 190,
Cubanac&#225;n, Playa, P.O. Box 6162, Havana 10600, Cuba.
carlos.duarte@cigb.edu.cu.
(10)Center for Genetic Engineering and Biotechnology, Ave 31/158 and 190,
Cubanac&#225;n, Playa, P.O. Box 6162, Havana 10600, Cuba.
viviana.falcon@cigb.edu.cu.
(11)Center for Genetic Engineering and Biotechnology, Ave 31/158 and 190,
Cubanac&#225;n, Playa, P.O. Box 6162, Havana 10600, Cuba.
osvaldo.reyes@cigb.edu.cu.
(12)Center for Genetic Engineering and Biotechnology, Ave 31/158 and 190,
Cubanac&#225;n, Playa, P.O. Box 6162, Havana 10600, Cuba.
hilda.garay@cigb.edu.cu.
(13)Laboratory for AIDS Research, Carretera de Tapaste y Autopista Nacional, San 
Jos&#233; de las Lajas, Mayabeque CP 32700, Cuba. eladio.silva@infomed.sld.cu.
(14)Laboratory for AIDS Research, Carretera de Tapaste y Autopista Nacional, San 
Jos&#233; de las Lajas, Mayabeque CP 32700, Cuba. enrnoa@infomed.sld.cu.
(15)Center for Genetic Engineering and Biotechnology, Ave 31/158 and 190,
Cubanac&#225;n, Playa, P.O. Box 6162, Havana 10600, Cuba.
yassel.ramos@cigb.edu.cu.
(16)Center for Genetic Engineering and Biotechnology, Ave 31/158 and 190,
Cubanac&#225;n, Playa, P.O. Box 6162, Havana 10600, Cuba.
vladimir.besada@cigb.edu.cu.
(17)Center for Genetic Engineering and Biotechnology, Ave 31/158 and 190,
Cubanac&#225;n, Playa, P.O. Box 6162, Havana 10600, Cuba.
lazaro.betancourt@cigb.edu.cu.

A combination of antiviral drugs known as antiretroviral therapy (ART) has shown 
effectiveness against the human immunodeficiency virus (HIV). ART has markedly
decreased mortality and morbidity among HIV-infected patients, having even
reduced HIV transmission. However, an important current disadvantage, resistance 
development, remains to be solved. Hope is focused on developing drugs against
cellular targets. This strategy is expected to prevent the emergence of viral
resistance. In this study, using a comparative proteomic approach in MT4 cells
treated with an anti-HIV leukocyte extract, we identified vimentin, a molecule
forming intermediate filaments in the cell, as a possible target against HIV
infection. We demonstrated a strong reduction of an HIV-1 based lentivirus
expressing the enhanced green fluorescent protein (eGFP) in vimentin knockdown
cells, and a noteworthy decrease of HIV-1 capsid protein antigen (CAp24) in those
cells using a multiround infectivity assay. Electron micrographs showed changes
in the structure of intermediate filaments when MT4 cells were treated with an
anti-HIV leukocyte extract. Changes in the structure of intermediate filaments
were also observed in vimentin knockdown MT4 cells. A synthetic peptide derived
from a cytoskeleton protein showed potent inhibitory activity on HIV-1 infection,
and low cytotoxicity. Our data suggest that vimentin can be a suitable target to 
inhibit HIV-1.

DOI: 10.3390/v8060098 
PMCID: PMC4926169
PMID: 27314381  [Indexed for MEDLINE]

